XP: Analysts Race to Catch a 52% Rally

Three distinct signals converged on XP Inc. this week. The Street is lifting targets, retail attention spiked sharply, and the options market shifted hard toward calls. All three arrived as the stock climbed 52% over the past month to $30.21.

Analysts Playing Catch-Up

The upgrade cycle is the clearest story here. Itau BBA lifted XP to Outperform on October 6, setting a $27 target. The stock had already run through that level by the time the note landed. UBS responded on October 8, raising its target from $25 to $37 while keeping its Buy rating. JP Morgan moved to $38 from $26, also maintaining Overweight.

Three firms raising targets within 72 hours is not routine housekeeping. It reflects a coordinated reassessment after the stock's 31% single-day surge on October 6. The consensus price target now sits above $134, though that figure reflects older, pre-rally estimates still in the pool. The live action from UBS and JP Morgan points to targets clustering in the $37 to $38 range.

Retail Piles In

ORTEX Alt Data shows retail attention at 4.6 standard deviations above its 90-day average on October 6, measured across English Wikipedia article views and ORTEX stock page traffic. That reading is not a revenue or earnings indicator. It reflects the surge in ordinary investor curiosity that typically follows a sharp price move. A stock that doubles in a month draws readers. That attention reading is now at 4.56 standard deviations above its own history, a level not seen in the prior 90 days of the series.

Options Shift: Calls Rule, but PCR Spikes Higher

The previous note from October 5 flagged a PCR of 0.07 as extreme bullishness. That ratio has now risen to 0.20, which sounds less bullish on the surface. The context matters: 0.20 is still a very low put/call ratio in absolute terms, meaning calls vastly outnumber puts. The spike is 2.73 standard deviations above the 20-day mean of 0.093. Traders may be hedging some of the move, or new participants are buying both sides after the surge. Either way, the options market remains call-heavy.

Corroborating Context

Mirae Asset Global Investments added 9.45 million shares as of September 30, one of the larger institutional additions in the holder table. BlackRock added 2.48 million shares over the same period. The borrow market remains loose: availability stands at 1,405% of current short interest, meaning shares to borrow are plentiful relative to existing shorts. Short interest sits at 4.5% of the free float, roughly where it was a week ago, and cost to borrow is 0.55%. Short sellers are not pressing the stock aggressively.

Earnings are scheduled for November 17, 39 days away.

Data Summary

• Price: $30.21, up 52% over one month, up 43% over one week
• Analyst targets: UBS $37, JP Morgan $38, Itau BBA $27 (upgrade)
• PCR: 0.20, z-score 2.73 above 20-day mean of 0.093
• Retail attention: 4.56 standard deviations above 90-day average (Wikipedia and ORTEX page views, October 6)
• SI: 4.47% of free float, borrow availability at 1,405%
• Next earnings: November 17, 2026